There may be fresh hope for prostate cancer patients who develop resistance to traditional forms of therapies, as oncologists say a new third-line treatment is showing promising results so far.
The Hong Kong Society of Uro-Oncology said the targeted radiotherapy treatment — lutetium-177-PSMA-617 — can boost cancer survival rates and improve patients’ quality of life…
阅读更多（Read More）